ATE123036T1 - Methode zur in vitro diagnose von hiv-1 virus infektionen. - Google Patents

Methode zur in vitro diagnose von hiv-1 virus infektionen.

Info

Publication number
ATE123036T1
ATE123036T1 AT92903700T AT92903700T ATE123036T1 AT E123036 T1 ATE123036 T1 AT E123036T1 AT 92903700 T AT92903700 T AT 92903700T AT 92903700 T AT92903700 T AT 92903700T AT E123036 T1 ATE123036 T1 AT E123036T1
Authority
AT
Austria
Prior art keywords
hiv
virus infections
vitro diagnosis
vitro
virus
Prior art date
Application number
AT92903700T
Other languages
English (en)
Inventor
Rossi Anita De
Marcella Pasti
Fabrizio Mammano
Marina Panozzo
Monica Dettin
Bello Carlo Di
Luigi Chieco-Bianchi
Original Assignee
Ist Superiore Sanita
Consiglio Nazionale Ricerche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ist Superiore Sanita, Consiglio Nazionale Ricerche filed Critical Ist Superiore Sanita
Application granted granted Critical
Publication of ATE123036T1 publication Critical patent/ATE123036T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT92903700T 1991-01-30 1992-01-29 Methode zur in vitro diagnose von hiv-1 virus infektionen. ATE123036T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI910220A IT1244529B (it) 1991-01-30 1991-01-30 Peptidi sintetici atti a potenziare l'infettivita' del virus hiv-1

Publications (1)

Publication Number Publication Date
ATE123036T1 true ATE123036T1 (de) 1995-06-15

Family

ID=11358323

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92903700T ATE123036T1 (de) 1991-01-30 1992-01-29 Methode zur in vitro diagnose von hiv-1 virus infektionen.

Country Status (10)

Country Link
US (1) US5527666A (de)
EP (1) EP0569428B1 (de)
JP (1) JPH06509637A (de)
AT (1) ATE123036T1 (de)
AU (1) AU1180392A (de)
DE (1) DE69202698T2 (de)
DK (1) DK0569428T3 (de)
ES (1) ES2073287T3 (de)
IT (1) IT1244529B (de)
WO (1) WO1992013882A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2192937B1 (es) * 2001-05-29 2005-01-01 Universidad Miguel Hernandez De Elche Peptidos activadores de la infectividad del rhabdovirus de la septicemia hemorragica virica (vhsv).
ES2639307T3 (es) * 2011-06-30 2017-10-26 Genethon Péptidos con propiedades potenciadoras de infección vírica y su uso

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017688A (en) * 1986-06-12 1991-05-21 Biogen, Inc. Peptides involved in the pathogenesis of HIV infection
AU640619B2 (en) * 1988-10-03 1993-09-02 Repligen Corporation Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
WO1990015078A1 (en) * 1989-06-05 1990-12-13 Scott Charles F Jr HUMAN MONOCLONAL ANTIBODIES TO HIV-1MN gp 120

Also Published As

Publication number Publication date
DK0569428T3 (da) 1995-07-24
US5527666A (en) 1996-06-18
DE69202698D1 (de) 1995-06-29
JPH06509637A (ja) 1994-10-27
ITMI910220A1 (it) 1992-07-30
DE69202698T2 (de) 1995-10-26
WO1992013882A1 (en) 1992-08-20
ES2073287T3 (es) 1995-08-01
EP0569428B1 (de) 1995-05-24
ITMI910220A0 (it) 1991-01-30
EP0569428A1 (de) 1993-11-18
AU1180392A (en) 1992-09-07
IT1244529B (it) 1994-07-15

Similar Documents

Publication Publication Date Title
ES2072853T3 (es) Retrovirus hiv-3 y su utilizacion.
ATE108068T1 (de) Antikörper-heterokonjugate zur töting von hiv- infizierten zellen.
ATE479742T1 (de) Verfahren zur grosstechnischen herstellung von impfstoffen
ATE116637T1 (de) Sulfonische stilbenderivate zur behandlung von viruserkrankungen.
DK614987D0 (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
ES2061495T3 (es) Peptidos relacionados con el virus htlv-iii, anticuerpos para los peptidos, vacunas, inmunizacion activa y pasiva contra el virus del sida y prueba diagnostica para la deteccion serologica del virus del sida.
ATE123036T1 (de) Methode zur in vitro diagnose von hiv-1 virus infektionen.
NO885090D0 (no) Polypeptider.
ATE125870T1 (de) Hiv-spezifische monoklonale antikörper und hybridome zu ihrer herstellung.
ATE105938T1 (de) Monoklonale antikörper gegen spezifische antigene regionen des humanen immundefizienzvirus und methoden zur verwendung.
KR900702045A (ko) 천연 hiv gp 160의 제조방법
ATE88752T1 (de) Inaktivierung von human immunodeficiency virus (hiv) in proteinhaltigen loesungen durch phenole.
DE69120925D1 (de) Hämoglobin-oligomer basierte komposition und seine herstellung
AU2190288A (en) Vector for the expression of proteins of the HIV-2 virus, one of the casual agents of AIDS, cell culture infected or transformed by this vector, proteins obtained, vaccine and antibodies obtained
SU1768637A1 (en) Strain of human immunodeficient virus 1-type for preparation of diagnostic preparation
ATE174507T1 (de) Verwendung eines benzimidazolwurmmittels zur behandlung von mikrosporeninfektionen
DK0426314T3 (da) HIV-relaterede peptider
ES496780A0 (es) Un procedimiento para el cultivo celular in vitro del virus de la hepatitis b.
SU1540269A1 (ru) Штамм гибридных культивируемых клеток животного mus musculus, используемый для получения моноклональных антител к поверхностному гликопротеину вирусов комплекса клещевого энцефалита
IE41024B1 (en) Process for obtaining antigens from schistosomes, agent containing these antigens and its use
Williams et al. Susceptibility of rodents to Japanese encephalitis virus
SE8701294D0 (sv) Hiv-peptid
RU94002006A (ru) Штамм культуры клеток человека нтн1 27 - продуцент вируса иммунодефицита человека (вич)
ATE87827T1 (de) Anti-hiv-wirkung von bu-3608.
DE68925191D1 (de) Peptide mit schutzeigenschaften gegen ein pathogenes virus des hiv-typs in sensitiven zellen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee